STABLE PHARMACEUTICAL COMPOSITION CONTAINING 8-[(3R)-3-AMINO-1-PIPERIDINYL]-7-(2-BUTYN-1-YL)-3,7-DIHYDRO-3-METHYL-1-[(4-METHYL-2-QUINAZOLINYL)METHYL]-1H-PURINE-2,6-DIONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

The present invention relates to a stable pharmaceutical composition comprising amorphous or crystalline linagliptin or a pharmaceutically acceptable salt of linagliptin, mannitol, copovidone, and magnesium stearate, processes for preparing the stable pharmaceutical composition, and a container comp...

Full description

Saved in:
Bibliographic Details
Main Authors SCHWARZ, FRANZ X, HOTTER, ANDREAS, ANKER, GEORG, BACHER, JOHANN
Format Patent
LanguageEnglish
French
Published 20.02.2014
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a stable pharmaceutical composition comprising amorphous or crystalline linagliptin or a pharmaceutically acceptable salt of linagliptin, mannitol, copovidone, and magnesium stearate, processes for preparing the stable pharmaceutical composition, and a container comprising the stable pharmaceutical composition.
Bibliography:Application Number: CA20132879003